New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 12, 2012
16:05 EDTWPI, SNYWatson Pharmaceuticals unit receives FDA approval of generic Avapro
Watson Pharmaceuticals (WPI) announced that its subsidiary Watson Laboratories, has received approval from the U.S. FDA on its Abbreviated New Drug Application for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic equivalent to Sanofi's (SNY) Avapro. Watson intends to begin shipping the product immediately. Avapro is indicated for the treatment of hypertension when used alone or in combination with other antihypertensive agents. It is also indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. For the 12 months ending August 31, Avapro and its generic equivalents had total U.S. sales of approximately $390M according to IMS Health data.
News For WPI;SNY From The Last 14 Days
Check below for free stories on WPI;SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 23, 2013
08:18 EDTSNYMerrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information
May 21, 2013
07:44 EDTSNYSachs Associates to host a forum
Subscribe for More Information
May 20, 2013
17:26 EDTSNYRegeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information
11:27 EDTSNYAppeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information
May 17, 2013
08:03 EDTSNYSanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information
05:18 EDTSNYSanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information
May 15, 2013
15:16 EDTSNYSanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information
05:39 EDTSNYSanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information
May 13, 2013
09:44 EDTSNYSeveral companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information
07:30 EDTSNYTechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16.
May 10, 2013
11:48 EDTSNYDrugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.